High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort-Reference-Cited by-同舟云学术

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

Published:2021-12-21 Issue:1 Volume:6 Page:e668
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Kroeze Emma,Weijers Dilys D.,Hagleitner Melanie M.,de Groot-Kruseman Hester A.,Jongmans Marjolijn C. J.,Kuiper Roland P.,Pieters Rob,Meijerink Jules P. P.,Loeffen Jan L. C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference12 articles.

1. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.;Landmann;Haematologica,2017

2. Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults.;Murphy;Semin Oncol,1980

3. Revised international pediatric non-Hodgkin lymphoma staging system.;Rosolen;J Clin Oncol,2015

4. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?;Kroeze;Blood Adv,2020

5. Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.;Khanam;Blood,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Insights and Potential Benefits of Stem Cell Transplantation for Constitutional Mismatch Repair Deficiency: A Case Report of Two Siblings;Cureus;2024-08-08

2. T‐cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities;HemaSphere;2024-05

3. Germline Predisposition in Hematologic Malignancies;Comprehensive Hematology and Stem Cell Research;2024

4. Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds;Immunology Letters;2023-11

5. Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies;Frontiers in Pediatrics;2023-02-07